Skip to content

About US
About LB-102
Pipeline
Publications
Investors
Careers
Contact Us

H.C. Wainwright 28th Annual Global Investment Conference

September 14, 2026

Presentation will be available virtually at 10:00 a.m. ET on Monday, September 14, 2026
Virtual 1×1 investor meetings on Monday, September 14, 2026

view ALL Events

About US
About LB-102
Pipeline
Publications
Investors
Careers
Contact Us

About US
About LB-102
Pipeline
Publications
Investors
Careers
Contact Us

All Rights Reserved.

About Us
Management
Board of Directors
Scientific Advisory Board
Careers
Contact Us

About LB-102
Pipeline
About Schizophrenia
Publications

Investors Overview
News
Events
Corporate Governance
SEC Filings
Stock Information
Analyst Coverage
Investor FAQs

© 2026 LB Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.

Expanded Access Policy
Privacy Policy

Scroll to Top